Globalization, TRIPS and Access to Pharmaceuticals - WHO Policy Perspectives on Medicines, No. 003, March 2001: Contacts at WHO Headquarters:

Globalization, TRIPS and Access to Pharmaceuticals - WHO Policy Perspectives on Medicines, No. 003, March 2001
(2001; 6 pages) [French] [Spanish]

Table of Contents

	A new era in global trade
	Key requirements of the TRIPS Agreement
	Public health and TRIPS
	Evaluating impacts of trade agreements
	WHO perspectives on access to drugs
	Further reading
	Contacts at WHO Headquarters:

Contacts at WHO Headquarters:

Essential Drugs and Medicines Policy
Health Technology and Pharmaceuticals Cluster

WHO Headquarters, Geneva, Switzerland:

Dr Jonathan Quick
Director, Essential Drugs and Medicines
Policy Department.
Tel: +41 22 791 4443.
Email: quickj@who.int

Dr Hans Hogerzeil
Team Coordinator, Policy, Access and Rational Use
Tel: +41 22 791 3528
Email: hogerzeilh@who.int

Dr Lembit Rägo
Team Coordinator, Quality and Safety:
Medicines
Tel: +41 22 791 4420
Email: ragol@who.int

Dr Germán Velásquez
Team Coordinator, Drug Action Programme
Tel: +41 22 791 3509
Email: velasquezg@who.int

Dr Xiaorui Zhang
Acting Team Coordinator, Traditional
Medicine
Tel: +41 22 791 3639
Email: zhangx@who.int

This document is not a formal publication of the World Health Organization (WHO), and all rights are reserved by the Organization. The document may, however, be freely reviewed, abstracted, reproduced and translated, in part or in whole, but not for sale nor for use in conjunction with commercial purposes. The views expressed in documents by named authors are solely the responsibility of those authors.